标题
Human Tumor Antigens and Cancer Immunotherapy
作者
关键词
-
出版物
Biomed Research International
Volume 2015, Issue -, Pages 1-17
出版商
Hindawi Limited
发表日期
2015-06-17
DOI
10.1155/2015/948501
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Survival follow-up and ipilimumab retreatment of patients with advanced melanoma who received ipilimumab in prior phase II studies
- (2014) C. Lebbe et al. ANNALS OF ONCOLOGY
- Programmed death-1 pathway in cancer and autoimmunity
- (2014) Ariel Pedoeem et al. CLINICAL IMMUNOLOGY
- Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab
- (2014) Suzanne L. Topalian et al. JOURNAL OF CLINICAL ONCOLOGY
- Vaccination of a Melanoma Patient with Mature Dendritic Cells Pulsed with MAGE-3 Peptides Triggers the Activity of Nonvaccine Anti-Tumor Cells
- (2014) J. Carrasco et al. JOURNAL OF IMMUNOLOGY
- A Spliced Antigenic Peptide Comprising a Single Spliced Amino Acid Is Produced in the Proteasome by Reverse Splicing of a Longer Peptide Fragment followed by Trimming
- (2014) A. Michaux et al. JOURNAL OF IMMUNOLOGY
- Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma
- (2013) G. P. Linette et al. BLOOD
- Therapeutic PD-1 Pathway Blockade Augments with Other Modalities of Immunotherapy T-Cell Function to Prevent Immune Decline in Ovarian Cancer
- (2013) J. Duraiswamy et al. CANCER RESEARCH
- Dual Blockade of PD-1 and CTLA-4 Combined with Tumor Vaccine Effectively Restores T-Cell Rejection Function in Tumors
- (2013) J. Duraiswamy et al. CANCER RESEARCH
- Mutated PPP1R3B Is Recognized by T Cells Used To Treat a Melanoma Patient Who Experienced a Durable Complete Tumor Regression
- (2013) Y.-C. Lu et al. JOURNAL OF IMMUNOLOGY
- Cancer Regression and Neurological Toxicity Following Anti-MAGE-A3 TCR Gene Therapy
- (2013) Richard A. Morgan et al. JOURNAL OF IMMUNOTHERAPY
- Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells
- (2013) Paul F Robbins et al. NATURE MEDICINE
- MHC Class I-Associated Phosphopeptides Are the Targets of Memory-like Immunity in Leukemia
- (2013) M. Cobbold et al. Science Translational Medicine
- Identification of a Titin-Derived HLA-A1-Presented Peptide as a Cross-Reactive Target for Engineered MAGE A3-Directed T Cells
- (2013) B. J. Cameron et al. Science Translational Medicine
- Transferred WT1-Reactive CD8+ T Cells Can Mediate Antileukemic Activity and Persist in Post-Transplant Patients
- (2013) A. G. Chapuis et al. Science Translational Medicine
- Shared mechanisms in stemness and carcinogenesis: lessons from oncogenic viruses
- (2013) Demetris Iacovides et al. Frontiers in Cellular and Infection Microbiology
- Cyclin-A1 represents a new immunogenic targetable antigen expressed in acute myeloid leukemia stem cells with characteristics of a cancer-testis antigen
- (2012) S. Ochsenreither et al. BLOOD
- Tryptophan Catabolism in Cancer: Beyond IDO and Tryptophan Depletion
- (2012) M. Platten et al. CANCER RESEARCH
- Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity
- (2012) Suzanne L Topalian et al. CURRENT OPINION IN IMMUNOLOGY
- Analysis of the Processing of Seven Human Tumor Antigens by Intermediate Proteasomes
- (2012) B. Guillaume et al. JOURNAL OF IMMUNOLOGY
- Driving Forces of Proteasome-catalyzed Peptide Splicing in Yeast and Humans
- (2012) Michele Mishto et al. MOLECULAR & CELLULAR PROTEOMICS
- Importance of TAP-independent processing pathways
- (2012) Claudia C. Oliveira et al. MOLECULAR IMMUNOLOGY
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combined vaccination and immunostimulatory antibodies provides durable cure of murine melanoma and induces transcriptional changes associated with positive outcome in human melanoma patients
- (2012) A.J. Robert McGray et al. OncoImmunology
- A novel category of antigens enabling CTL immunity to tumor escape variants: Cinderella antigens
- (2011) Ursula J. E. Seidel et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Viral Vector-Based Therapeutic Cancer Vaccines
- (2011) Cecilia Larocca et al. CANCER JOURNAL
- A novel tumor-associated antigen, cell division cycle 45-like can induce cytotoxic T-lymphocytes reactive to tumor cells
- (2011) Yusuke Tomita et al. CANCER SCIENCE
- Insights into the processing of MHC class I ligands gained from the study of human tumor epitopes
- (2011) Nathalie Vigneron et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Proteasome subtypes and the processing of tumor antigens: increasing antigenic diversity
- (2011) Nathalie Vigneron et al. CURRENT OPINION IN IMMUNOLOGY
- Peptide transporter TAP mediates between competing antigen sources generating distinct surface MHC class I peptide repertoires
- (2011) Cláudia C. Oliveira et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- A MAGE-C2 antigenic peptide processed by the immunoproteasome is recognized by cytolytic T cells isolated from a melanoma patient after successful immunotherapy
- (2011) Wenbin Ma et al. INTERNATIONAL JOURNAL OF CANCER
- Minimal Tolerance to a Tumor Antigen Encoded by a Cancer-Germline Gene
- (2011) I. J. Huijbers et al. JOURNAL OF IMMUNOLOGY
- The carboxypeptidase ACE shapes the MHC class I peptide repertoire
- (2011) Xiao Z Shen et al. NATURE IMMUNOLOGY
- Mice completely lacking immunoproteasomes show major changes in antigen presentation
- (2011) Eleanor Z Kincaid et al. NATURE IMMUNOLOGY
- Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
- (2011) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- An antigenic peptide produced by reverse splicing and double asparagine deamidation
- (2011) A. Dalet et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- HLA-A2-restricted T-cell epitopes specific for prostatic acid phosphatase
- (2010) Brian M. Olson et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Differences in the production of spliced antigenic peptides by the standard proteasome and the immunoproteasome
- (2010) Alexandre Dalet et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Splicing of Distant Peptide Fragments Occurs in the Proteasome by Transpeptidation and Produces the Spliced Antigenic Peptide Derived from Fibroblast Growth Factor-5
- (2010) A. Dalet et al. JOURNAL OF IMMUNOLOGY
- Deletion of Immunoproteasome Subunits Imprints on the Transcriptome and Has a Broad Impact on Peptides Presented by Major Histocompatibility Complex I molecules
- (2010) Danielle de Verteuil et al. MOLECULAR & CELLULAR PROTEOMICS
- Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
- (2010) Richard A Morgan et al. MOLECULAR THERAPY
- T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient Colitis
- (2010) Maria R Parkhurst et al. MOLECULAR THERAPY
- Antigen processing by nardilysin and thimet oligopeptidase generates cytotoxic T cell epitopes
- (2010) Jan H Kessler et al. NATURE IMMUNOLOGY
- Production of an antigenic peptide by insulin-degrading enzyme
- (2010) Nicolas Parmentier et al. NATURE IMMUNOLOGY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Two abundant proteasome subtypes that uniquely process some antigens presented by HLA class I molecules
- (2010) B. Guillaume et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen
- (2009) L. A. Johnson et al. BLOOD
- Anti-Programmed Death-1 Synergizes with Granulocyte Macrophage Colony-Stimulating Factor-Secreting Tumor Cell Immunotherapy Providing Therapeutic Benefit to Mice with Established Tumors
- (2009) B. Li et al. CLINICAL CANCER RESEARCH
- Functional significance of tapasin membrane association and disulfide linkage to ERp57 in MHC class I presentation
- (2009) Nathalie Vigneron et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study
- (2009) Jedd D Wolchok et al. LANCET ONCOLOGY
- Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia
- (2009) Gemma G. Kenter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Induction of Tumor-Specific CD4+ and CD8+ T-Cell Immunity in Cervical Cancer Patients by a Human Papillomavirus Type 16 E6 and E7 Long Peptides Vaccine
- (2008) M. J.P. Welters et al. CLINICAL CANCER RESEARCH
- Favorable outcome in clinically stage II melanoma patients is associated with the presence of activated tumor infiltrating T-lymphocytes and preserved MHC class I antigen expression
- (2008) Inge S. van Houdt et al. INTERNATIONAL JOURNAL OF CANCER
- Novel MITF targets identified using a two-step DNA microarray strategy
- (2008) Keith S. Hoek et al. Pigment Cell & Melanoma Research
- Preprocalcitonin signal peptide generates a cytotoxic T lymphocyte-defined tumor epitope processed by a proteasome-independent pathway
- (2008) F. El Hage et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started